A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease

NCT02880956 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

453

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: ABBV-8E12
DRUG: placebo for ABBV-8E12

Sponsor

AbbVie